Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 96 | 1 | 92 | −3 |
| Shares | 30.8M | 114.8K | 29.9M | −738.1K (−2.4%) |
| Value | $306.0M | $1.14M | $290.5M | −$14.4M (−4.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 523,528 | $5.07M | 0.27% |
| Woodline Partners LP | 332,893 | $3.23M | 0.05% |
| D. E. Shaw & Co., Inc. | 42,928 | $416.0K | 0.00% |
| Jump Financial, LLC | 23,819 | $231.0K | 0.01% |
| Engineers Gate Manager LP | 14,482 | $140.0K | 0.01% |
| Lindbrook Capital, LLC | 23 | $0 | 0.00% |
Sold out (9)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 329,798 | $3.28M |
| Jackson Creek Investment Advisors LLC | 81,995 | $815.0K |
| HRT Financial LP | 58,874 | $585.0K |
| Susquehanna International Group, LLP | 30,868 | $307.0K |
| Vigilare Wealth Management | 22,720 | $226.0K |
| Northeast Financial Consultants Inc | 10,130 | $101.0K |
| UBS Group AG | 1,173 | $12.0K |
| US Bancorp | 610 | $6.00K |
| Aquatic Capital Management LLC | 200 | $2.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 114,766 | $1.14M |